Has Andrew Huang, MD received payments from drug or device companies?

Yes. Drug and device makers reported $284 in general payments to Andrew Huang, MD across 5 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Andrew Huang, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Andrew Huang, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Andrew Huang, MD

Radiation Oncology · Wausau, WINPI 1679957526

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 5 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Merck at 47.2% of the total.

$284in general payments, 2019–2025

Across 5 payments — averaging $56.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$134
Novartis$64
EMD Serono, Inc.$45
Johnson & Johnson$40

What the payments were for

Food & beverage$284100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	1	$134
Novartis	2	$64
EMD Serono, Inc.	1	$45
Johnson & Johnson	1	$40

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

KEYTRUDA$134

How this compares

$284 in reported general payments places this provider in the 65th percentile of 131 radiation oncology providers in Wisconsin.

See all radiation oncology providers in Wisconsin →

Medicare billing

Part B allowed, 2024

$333,912

Medicare patients

250

Services billed

3,705

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OrgovyxRelugolix	121	$317,859
Tamsulosin Hcl	67	$986
Memantine Hcl ErMemantine Hcl	11	$875
Oxybutynin Chloride ErOxybutynin Chloride	61	$640
Triamcinolone Acetonide	58	$532
Dexamethasone	32	$380
SsdSilver Sulfadiazine	13	$208
Lorazepam	21	$22

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Wausau

Anna BrownWausau$9K
Christopher PlattaWausau$687
Timothy KruserMadison$235K
Stephen RosenbergMadison$18K
Matthew WitekMadison$11K
Joseph BoviMilwaukee$6K
William HallMilwaukee$5K
Jessica SchusterJohnson Creek$5K
Lindsay PuckettMilwaukee$4K
Douglas CalvinAppleton$4K

See the full list for Wisconsin →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →